WEST CHESTER, Ohio, Feb. 26, 2019 /PRNewswire/ -- Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today's highest standards for product quality and cost-efficient delivery.
Aniara would like to highlight the availability of Hyphen BioMed's Biophen Heparin LRT, a ready to use liquid reagent. Biophen Heparin LRT is a chromogenic anti-Xa method for measuring homogenously Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH), using the same calibration curve (kinetics method, one stage). The assay can also be used for testing heparin analogues, such as Sodium Danaparoid (Orgaran), or Fondaparinux (Arixtra), and direct Factor Xa Inhibitors such as Rivaroxaban and Apixaban, using automatic or manual methods.
Biophen Heparin LRT is CE marked and licensed in Canada
Biophen Heparin LRT comes in 3 different sizes
- Biophen Heparin LRT (4 x 7.5mL) (221011)
- Biophen Heparin LRT (3 x 3mL) (221013)
- Biophen Heparin LRT (4 x 5mL) (221015)
Available Calibrators and controls for the Biophen Heparin LRT include
For specific product information please visit www.aniara.com
Aniara Distributes Hyphen BioMed's entire line of diagnostic and research reagents for Thrombosis, Hemostasis, and Autoimmunity.
The entire Aniara product line is available for purchase at www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
7768 Service Center Drive
West Chester, OH 45069
SOURCE Aniara Diagnostica